Related Experiment Videos
Discovery of nonsteroidal androgens
J T Dalton1, A Mukherjee, Z Zhu
1Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee, Memphis 38163, USA. JDALTON@UTMEM1.UTMEM.EDU
Biochemical and Biophysical Research Communications
|March 26, 1998
Summary
Researchers developed novel non-steroidal androgens that bind to the androgen receptor. These compounds mimic dihydrotestosterone, showing potential for male fertility and hormone replacement therapies.
Area of Science:
- Endocrinology
- Molecular Pharmacology
- Medicinal Chemistry
Background:
- Nonsteroidal androgens have not been previously reported in scientific literature.
- The androgen receptor (AR) is a key nuclear receptor regulating gene expression involved in male sexual development and function.
Purpose of the Study:
- To identify novel affinity ligands for the androgen receptor.
- To synthesize and characterize nonsteroidal ligands with potential androgenic activity.
- To explore new therapeutic agents for conditions related to androgen deficiency.
Main Methods:
- Synthesis of electrophilic nonsteroidal ligands targeting the androgen receptor.
- Assessment of ligand binding affinity to the androgen receptor.
- Evaluation of the ability of synthesized ligands to stimulate receptor-mediated transcriptional activation.
Main Results:
- Three synthesized nonsteroidal ligands demonstrated binding affinity to the androgen receptor comparable to dihydrotestosterone (DHT).
- These ligands successfully mimicked the effects of DHT, acting as potent androgen receptor agonists.
- Established that nonsteroidal ligands can be structurally engineered to exhibit agonist activity.
Conclusions:
- Identified the first class of nonsteroidal androgens with significant receptor binding and agonist activity.
- These novel compounds represent a potential breakthrough for therapeutic applications in male fertility.
- The findings open new avenues for hormone replacement therapy and treatment of androgen-related disorders.